Professor Amy Brodtmann has further committed to raising awareness and educating about dementia through her newest role as Dementia Australia Honorary Medical Advisor.
Dementia Australia CEO Maree McCabe officially welcomed Prof Brodtmann to the position, saying she has long been involved in Dementia Australia, and had made an enormous contribution both to the organisation and, more broadly, to dementia treatment, care and research both in Australia and internationally. Amy also has a special interest in Fronto Temporal Dementia and was a founding member of the Australian Frontotemporal Dementia Association, the inaugural Chair of the Australian chapter of the Organization of Human Brain Mapping, the inaugural President of the Australian Cognitive Neurology Society and is a member of the Wicking Strategic Review Panel.
“We are very fortunate to have had Amy’s expertise, guidance and support in various capacities for so many years and I am delighted that we can continue the relationship in such a significant way,” Ms McCabe said.
Prof Brodtmann said she was delighted to continue supporting Dementia Australia in her new capacity as Dementia Australia Honorary Medical Advisor.
“Dementia has long been a focus of my research and I am looking forward to further contributing to Dementia Australia through the knowledge and expertise I have gained through my work,” Prof Brodtmann said.
Prof Brodtmann is a stroke and cognitive neurologist at the Royal Melbourne Hospital, Austin Health, and Eastern Health. She is co-head of the Dementia Theme at the Florey Institute for Neuroscience and Mental Health and holds professorial appointments at both the University of Melbourne and Monash University.
Her research focuses on the imaging of brain network degenerations following stroke, cardiovascular contributions to cognitive impairment, and the diagnosis and management of focal onset dementias. She is on the